Bristol-Myers Squibb Company
BMY
$59.01
-$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
Weiss Ratings | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C | |||
Rating Factors | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.20 | |||
Price History | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.35% | |||
30-Day Total Return | -0.22% | |||
60-Day Total Return | 6.96% | |||
90-Day Total Return | 6.98% | |||
Year to Date Total Return | 5.05% | |||
1-Year Total Return | 18.04% | |||
2-Year Total Return | -3.11% | |||
3-Year Total Return | -4.18% | |||
5-Year Total Return | 38.29% | |||
52-Week High % Change | -4.82% | |||
52-Week Low % Change | 53.19% | |||
Price | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $63.33 | |||
52-Week Low Price | $39.35 | |||
52-Week Low Price (Date) | Jul 05, 2024 | |||
52-Week High Price (Date) | Mar 11, 2025 | |||
Valuation | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 122.33B | |||
Enterprise Value | 162.46B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -4.43 | |||
Earnings Per Share Growth | -214.81% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 2.54 | |||
Price/Book (Q) | 7.49 | |||
Enterprise Value/Revenue (TTM) | 3.36 | |||
Price | $59.01 | |||
Enterprise Value/EBITDA (TTM) | 8.35 | |||
Enterprise Value/EBIT | 16.45 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.04B | |||
Dividend Yield | 4.01% | |||
Div. Per Share (Most Recent) | $0.62 | |||
Dividend Per Share (TTM) | $2.42 | |||
Payout Ratio (TTM) | -54.35% | |||
Dividend Per Share (Most Recent) | $0.62 | |||
Company Info | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 609 252 4621 | |||
Address | Route 206 & Province Line Road Princeton, NJ 08543 | |||
Website | www.bms.com | |||
Country | United States | |||
Year Founded | 1887 | |||
Profitability | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 20.44% | |||
Profit Margin | -18.52% | |||
Management Effectiveness | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 6.57% | |||
Return on Equity | -- | |||
Income Statement | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 48.30B | |||
Total Revenue (TTM) | 48.30B | |||
Revenue Per Share | $23.71 | |||
Gross Profit (TTM) | 36.35B | |||
EBITDA (TTM) | 19.45B | |||
EBIT (TTM) | 9.88B | |||
Net Income (TTM) | -8.95B | |||
Net Income Avl. to Common (TTM) | -8.95B | |||
Total Revenue Growth (Q YOY) | 7.54% | |||
Earnings Growth (Q YOY) | -95.69% | |||
EPS Diluted (TTM) | -4.43 | |||
EPS Diluted Growth (Q YOY) | -95.91% | |||
Balance Sheet | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 10.86B | |||
Cash Per Share (Q) | $5.33 | |||
Total Current Assets (Q) | 29.78B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 16.39B | |||
Current Ratio (Q) | 1.253 | |||
Book Value Per Share (Q) | $8.05 | |||
Total Assets (Q) | 92.60B | |||
Total Current Liabilities (Q) | 23.77B | |||
Total Debt (Q) | 51.26B | |||
Total Liabilities (Q) | 76.22B | |||
Total Common Equity (Q) | 16.34B | |||
Cash Flow | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -21.35B | |||
Cash from Financing (TTM) | 5.13B | |||
Net Change in Cash (TTM) | -1.17B | |||
Levered Free Cash Flow (TTM) | 17.59B | |||
Cash from Operations (TTM) | 15.19B | |||